FAPI-46 is a quinoline-based fibroblast activation protein (FAP)-targeted radiotracer. FAPI-46 has higher tumor uptake and prolonged tumor accumulation. FAPI-46 can be used for tumor imaging of a multitude of different cancers.
性状
Solid
IC50 & Target[1][2]
fibroblast activation protein (FAP)
体外研究(In Vitro)
FAPI-46 (1-24 h) robustly binds to human FAP in human FAP-expressing HT-1080 cells. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
FAPI-46 (i.v.) shows improved ratios of tumor to liver, kidney, and brain uptake, resulting in an enhanced image contrast for PET imaging. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
ClinicalTrial
参考文献
[1]. Loktev A, et, al. Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention. J Nucl Med. 2019 Oct;60(10):1421-1429.[2]. Moon ES, et, al. Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA 5m chelators. EJNMMI Radiopharm Chem. 2020 Jul 29;5(1):19.
溶解度数据
In Vitro: H2O : 100 mg/mL (112.87 mM; Need ultrasonic)DMSO : 100 mg/mL (112.87 mM; Need ultrasonic)配制储备液